We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New AI Technology Can Determine Best Type of Cancer Treatment

By HospiMedica International staff writers
Posted on 23 Jan 2019
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
A team of researchers from Case Western Reserve University (Cleveland, OH, USA) is using artificial intelligence (AI) and smart-imaging computer technology for viewing routine medical images — MRIs, CAT scans, tissue biopsies — to determine the best type of cancer treatment.

In addition to detecting patterns beyond what the human eye can see, AI and computers can also determine the likelihood that a patient is going to respond to chemotherapy. A significant number of patients receive a cancer diagnosis, but also get over-treated and over-diagnosed. A recent study in the American Journal of Medicine found that 42% of new cancer patients lose their complete life savings in two years for treatment.

The researchers believe that a significant reduction can be brought about in the number of surgeries and of biopsies in patients who do not require them because they have benign nodules. Their research has been able to determine whether breast cancer patients, and more recently lung cancer patients, need chemotherapy. The technology would not reduce the number of jobs for pathologists or radiologists, but assist them and other clinicians.

Related Links:
Case Western Reserve University
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
ow Frequency Pulse Massager
ET10 L

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more